These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 34242696)
1. The multifaceted role of cathepsins in liver disease. Ruiz-Blázquez P; Pistorio V; Fernández-Fernández M; Moles A J Hepatol; 2021 Nov; 75(5):1192-1202. PubMed ID: 34242696 [TBL] [Abstract][Full Text] [Related]
2. Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges. Brix K; McInnes J; Al-Hashimi A; Rehders M; Tamhane T; Haugen MH Protoplasma; 2015 May; 252(3):755-74. PubMed ID: 25398648 [TBL] [Abstract][Full Text] [Related]
4. Tissue Levels of Stefin A and Stefin B in Hepatocellular Carcinoma. Lin YY; Chen ZW; Lin ZP; Lin LB; Yang XM; Xu LY; Xie Q Anat Rec (Hoboken); 2016 Apr; 299(4):428-38. PubMed ID: 26753874 [TBL] [Abstract][Full Text] [Related]
6. Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials. Liu CL; Guo J; Zhang X; Sukhova GK; Libby P; Shi GP Nat Rev Cardiol; 2018 Jun; 15(6):351-370. PubMed ID: 29679024 [TBL] [Abstract][Full Text] [Related]
7. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. Sircana A; Paschetta E; Saba F; Molinaro F; Musso G Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970564 [TBL] [Abstract][Full Text] [Related]
8. Autophagy and non-alcoholic fatty liver disease. Lavallard VJ; Gual P Biomed Res Int; 2014; 2014():120179. PubMed ID: 25295245 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Su Q; Kumar V; Sud N; Mahato RI Adv Drug Deliv Rev; 2018 Apr; 129():54-63. PubMed ID: 29391222 [TBL] [Abstract][Full Text] [Related]
10. Osteopontin - A potential biomarker of advanced liver disease. Bruha R; Vitek L; Smid V Ann Hepatol; 2020; 19(4):344-352. PubMed ID: 32005637 [TBL] [Abstract][Full Text] [Related]
11. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis. Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434 [TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237 [TBL] [Abstract][Full Text] [Related]
16. The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation. Campden RI; Zhang Y Arch Biochem Biophys; 2019 Jul; 670():32-42. PubMed ID: 30807742 [TBL] [Abstract][Full Text] [Related]
17. Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants. Zhang Y; Li K; Kong A; Zhou Y; Chen D; Gu J; Shi H Ecotoxicol Environ Saf; 2021 Jul; 217():112256. PubMed ID: 33901779 [TBL] [Abstract][Full Text] [Related]